Skip to main content


Freshfields Advises AmerisourceBergen on Acquisition of PharmaLex

Freshfields is advising AmerisourceBergen Corporation (NYSE: ABC) on its €1.28bn cash acquisition of PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry. More details about the transaction can be found here.

The cross-border Freshfields team is led by M&A Partners Damien Zoubek (NY), Dr. Lars Meyer (Frankfurt) and Dr. Philipp Puetz (Dusseldorf) and Associate Sandy Ge (Dusseldorf).

Additional support on corporate matters is provided by Associate Nicholas Lütgerath (NY) and Associate Gillian Farrell (London). Associates Jonas Braun (Dusseldorf) and Henri Conze (Dusseldorf) are providing support on German corporate matters.

In the US, Partner Jan Rybnicek (Washington) and Special Counsel Charles Ramsey (Washington) are advising on antitrust matters; Partner Lori Goodman (NY) and Associates Jefferey Anand (NY) and Sonia Bennett (NY) are advising on compensation and benefits matters; and Partner Joe Solits (NY) is advising on tax matters.

In Germany, Partner Michael Ramb (Dusseldorf) and Associate Katharina Reinhardt (Berlin) are advising on regulatory matters; Partner Thomas Granetzny (Dusseldorf) and Associate Tobias Kalb (Munich) are advising on compensation and benefits matters; and Partner Christian Ruoff (Hamburg) and Associate Dr. Anna Binder-Gutwinski (Vienna) are advising on tax matters.


About Freshfields Bruckhaus Deringer LLP

Freshfields Bruckhaus Deringer LLP is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.

Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit

This material is for general information only and is not intended to provide legal advice. Prior results do not guarantee a similar outcome.